BML Inc. (4694) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for BML Inc. (4694:JPX), powered by AI.

Current Price
¥3,625
P/E Ratio
22.6
Market Cap
141.3B
Sector
Healthcare
What is the BML Inc. stock price forecast?

BML Inc. is currently trading at ¥3,625. View real-time AI analysis on Alpha Lenz.

What is BML Inc. insider trading activity?

View the latest insider trading data for BML Inc. on Alpha Lenz.

What is BML Inc.'s P/E ratio?

BML Inc.'s P/E ratio is 22.6.

BML Inc.

JPX · 4694
¥3,625-15(-0.41%)Market closedJPX regular session 09:00–15:00 JST
Ask about BML Inc.'s future dividend policy...
Alpha Chat Insight

BML Inc. trades at a P/E of 22.6 (fair value) with modest ROE of 4.9%.

Ask for details

Company Overview

BML Inc. is a prominent player in the pharmaceutical and biotechnology sector, primarily focused on developing and providing a diverse range of diagnostic solutions. The company's core function is to enhance healthcare through innovative diagnostic methodologies, which include laboratory testing services, clinical diagnostics, and bioanalytical assessments. Notably, BML Inc. plays a crucial role in disease prevention and early diagnosis, significantly impacting health outcomes by facilitating timely and accurate medical decisions. The company is pivotal in the healthcare industry, offering its services to hospitals, clinics, research institutions, and pharmaceutical companies, thereby supporting comprehensive patient care and treatment solutions. With its commitment to advancing medical diagnostics, BML Inc. continues to hold a significant position in enhancing healthcare quality and efficiency across various markets worldwide.

SectorHealthcare
IndustryDiagnostics & Research
Employees4,558

Company Statistics

FY 2025

Profile

¥141,348,367,125Market Cap
¥143,191,000,000Revenue
0.00Shares Out
4,558Employees

Margins

32.03%Gross
12.43%EBITDA
6.54%Operating
6.76%Pre-Tax
4.55%Net

Valuation

22.57P/E
1.09P/B
0.99EV/Sales
4.69EV/EBITDA
-166.49P/FCF

Growth (CAGR)

-8.36%Rev 3Yr
3.47%Rev 5Yr
-42.36%Op Inc 3Yr
-0.83%Op Inc 5Yr
-42.74%Net Inc 3Yr
-0.87%Net Inc 5Yr

Returns

3.74%ROA
4.91%ROE
5.62%ROIC

Financial Health

¥67,562,000,000Cash & Cash Equivalents
¥-23,825,000,000Net Debt
32.70%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

BML Inc. (ticker: 4694) is a company listed on JPX in the Healthcare sector (Diagnostics & Research). It has approximately 4,558 employees. Market cap is $141.3B.

The current price is 3,625 with a P/E ratio of 22.57x and P/B of 1.09x.

ROE is 4.91% and operating margin is 6.54%. Annual revenue is $143.2B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
BML Inc. (4694) Stock Forecast 2026 ¥3,625 — Price, Financials & Analyst Targets | Alpha Lenz